DR ANTHONY MELVIN CRASTO,WorldDrugTracker, helping millions, A 90 % paralysed man in action for you, I am suffering from transverse mylitis and bound to a wheel chair,With death on the horizon, This will not stop me, Gods call only..........
DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 29Yrs Exp. in the feld of Organic Chemistry,Working for GLENMARK PHARMA at Navi Mumbai, INDIA. Serving chemists around the world. Helping them with websites on Chemistry.Million hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contributio
n

Tuesday 29 March 2016

Chafiq Hamdouchi Senior Research Advisor at Eli Lilly and Company

Chafiq Hamdouchi.

Chafiq Hamdouchi

Senior Research Advisor at Eli Lilly and Company


 LINKS


  • Department of Discovery Chemistry Research
    Indianapolis, Surrey, United Kingdom

Summary

Dr. Hamdouchi earned his bachelor’s degree and doctorate in organic chemistry from Louis Pasteur University, Strasbourg-France.
Following two postdoctoral fellowships, sponsored by the National Science Foundation-USA and Ministerio de Educación y Ciencia-Spain, he joined Eli Lilly and Company in 1995.
Throughout his 20 years of career at Lilly, he has contributed to a sustainable drug discovery portfolio from preclinical hypothesis to clinical proof-of-concept that spans the oncology, neuroscience and endocrinology therapeutic areas. He has led multidisciplinary (chemistry, pharmacology, ADMET, PK, medical) scientific teams in USA, Europe and Asia to deliver a number of compounds that achieved first human dose.
He is a co-inventor of six innovative molecules being pursued in clinical development for the treatment of Diabetes, Cancer and Neurodegenerative Diseases.
He has an extensive patent and publication record and deep experience in conducting drug discovery and development in Asia through effective partnership and mentorship.



Experience

Senior Research Advisor

Eli Lilly and Company
– Present (5 years 3 months)Lilly Research Laboratories, Lilly Corporate Center, Indianapolis

Research Advisor

Eli Lilly and Company
(5 years 1 month)

Principal Research Scientist

Eli Lilly and Company
(3 years 1 month)

Research Scientist

Eli Lilly and Company
(4 years 1 month)

Senior Organic Chemist

Eli Lilly and Company
(4 years 10 months)

Assistant Professor

Universidad Autónoma de Madrid
(2 years)

Patents

Preparation of spiropiperidine derivatives for use as antidiabetic agents(Link)

United States WO 2011066183 A1
Issued June 3, 2011

Preparation of imidazo-​pyridine derivatives as p38 kinase inhibitors(Link)

United States WO 2005075478 A1
Issued August 18, 2005

Spirocyclic C-glycosides

United States US19990342073
Filed 1999

Preparation of isopropyl triazolopyridine compounds for treating diabetes(Link)

United States WO 2015105779 A1
Issued January 16, 2015

Preparation of novel triazolo-​pyridine compounds for treating diabetes(Link)

United States WO 2015088868 A1
Issued June 18, 2015

Education

Florida State University

National Science Foundation (NSF) Postdoctoral Fellowship, Organic Chemistry

Université Louis Pasteur (Strasbourg I)

Doctor of Philosophy (Ph.D.), Organic Chemistry

Université Louis Pasteur (Strasbourg I)

Bachelor's Degree, Chemistry








/////

No comments:

Post a Comment